Author:
Yeung P. K. F.,Prescott C.,Haddad C.,Montague T. J.,McGregor C.,Quilliam M. A.,Xei M.,Li R.,Farmer P.,Klassen G. A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference24 articles.
1. Bourassa M.G. (1985): Haemodynamic and electrophysiologic effects of diltiazem. Acta Pharmacol. Toxicol., 57, Suppl. II, 21–30.
2. Kendall M.J. Okopski J.V. (1986): Calcium antagonism-with special reference to diltiazem. J. Clin. Hosp. Pharm., 11, 159–174.
3. Halperin A.K., Cubeddu L.X., Albuquerque N.M. (1986): The role of calcium channel blockers in the treatment of hypertension. Am. Heart J., 111 (2), 363–382.
4. Meshi T., Sugihara J., Sato Y. (1971): Metabolic fate of d-cis-3-acetoxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride (CRD-401). Chem. Pharm. Bull., 19, 1546–1556.
5. Sugihara J., Sugawara Y., Ando H., Harigaya S., Etoh A., Kohno K. (1984): Studies on the metabolism of diltiazem in man. J. Pharmacobiodyn., 7, 24–32.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献